Plus Therapeutics Inc (NASDAQ:PSTV)

2.75
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
2.16
Today|||52-Week Range
24.45
-81.03%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Plus Therapeutics Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +336.36% increase from the last price of 2.75.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Plus Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$5.85
Sales
$0.00
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 77.32%
 
 
 
 
 
 
Growthannually 71.23%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -70.18%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.